William Blair Reaffirms “Outperform” Rating for Bandwidth (NASDAQ:BAND)
Bandwidth (NASDAQ:BAND – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at William ...
Research Analysts Issue Forecasts for BMY Q1 Earnings
William Blair reduced their Q1 2026 EPS estimates for Bristol-Myers Squibb in a research report issued to clients and ...
Hosted on MSN1d
William Blair Downgrades CACI International (CACI)
Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...
BioSpace3d
5 Pharma Powerhouses Facing Massive Patent Cliffs—And What They’re Doing About It
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Booz Allen downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...
Radcom (RDCM) Gets a Buy from William Blair
William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...
William Blair Names John Ivey, B.T. Remmert Co-Heads of Technology Investment Banking
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...
Pediatrix Q4 Beats Estimates As Operational Improvements Drive Performance
Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...